Company profile: Clene
1.1 - Company Overview
Company description
- Provider of nanomedicine therapeutics for neurodegenerative diseases (ALS, MS, Parkinson's Disease), infectious diseases, and oncology applications: CNM-Au8 oral gold nanocrystals; CNM-ZnAg zinc-silver ionic solution with antiviral/antimicrobial properties; CNM-AgZn17 topical silver/zinc gel for infections and wound healing; CNM-PtAu7 gold-platinum nanotherapeutic with efficacy across tumor cell lines in initial research.
Products and services
- CNM-Au8: An oral, nanocrystal-based suspension of gold nanocrystals aimed at treating neurodegenerative diseases, specifically ALS, MS, and Parkinson's Disease
- CNM-AgZn17: A topical, gel-polymer suspension of silver and zinc ions developed for treating infectious diseases and accelerating wound healing across dermal applications
- CNM-ZnAg: A zinc-silver, ionic solution comprising zinc and silver ions and exhibiting antiviral and antimicrobial properties against microorganisms
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clene
Vivani Medical
HQ: United States
Website
- Description: Provider of implantable visual prosthetics for blind individuals and developer of NanoPortal technology for miniature, subdermal drug implants delivering steady medication, including NPM-115 for chronic weight management and NPM-119 (under development) for type 2 diabetes; via subsidiary Cortigent, develops targeted neurostimulation for artificial vision and muscle movement restoration in stroke rehabilitation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivani Medical company profile →
Credence MedSystems
HQ: United States
Website
- Description: Provider of drug delivery and specialty pharmaceutical solutions focused on safe medication administration, offering syringe systems including the Companion Safety Syringe with end-of-dose cues, passive needlestick safety, reuse prevention and pre-attached needle; Dual Chamber Reconstitution Syringe; Credence Connect for real-time injection monitoring; Micro-Dose Syringe for ocular use; and Multi-Site Syringe.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Credence MedSystems company profile →
MedinCell
HQ: France
Website
- Description: Provider of injectable slow-release drug expertise.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedinCell company profile →
Focal Medical
HQ: United States
Website
- Description: Provider of targeted therapeutic products using its patent-protected iontophoresis-based delivery system, including IOP Gemcitabine for locally advanced nonresectable pancreatic cancer, IOP Cisplatin for locally recurrent oral cavity cancer, and a program for targeted delivery of genomic medicine to organs without viral vectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Focal Medical company profile →
Oval Medical Technologies
HQ: United States
Website
- Description: Provider of specialty pharmaceutical autoinjector platforms: ArQ subcutaneous two-step autoinjector with audible feedback, compatible with various viscosities, volumes, and needle gauges; Bios platform for large-volume, ultra-high viscosity formulations using ISO-standard plunger stoppers and staked-needle syringes; Vita resuspension platform for delivering large volumes with a dry-needle system for long-acting formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oval Medical Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clene
2.2 - Growth funds investing in similar companies to Clene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clene
4.2 - Public trading comparable groups for Clene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →